Robert Myles Elfont
66 year
Consumer Services
Health Technology
Career history of Robert Myles Elfont
Former positions of Robert Myles Elfont
| Companies | Position | Start | End |
|---|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/03/2014 | - |
Training of Robert Myles Elfont
| University of Pennsylvania | Undergraduate Degree |
| University of Rochester Medical Center | Doctorate Degree |
Statistics
International
| United States | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Stock Market
- Insiders
- Robert Myles Elfont
- Experience
